E. Alrawi

Most-cited papers

1. Diffuse alveolar hemorrhage is most often fatal and is affected by graft source, conditioning regimen toxicity, and engraftment kinetics

   F. Keklik, E. Alrawi, Q. Cao, N. Bejanyan +12 more

   2018Haematologica26 citations Open access

   Semantic Scholar

   Save

2. Outcome of azacitidine treatment in patients with therapy-related myeloid neoplasms with assessment of prognostic risk stratification models.

   V. Duong, J. Lancet, E. Alrawi, Najla Al-Ali +6 more

   2013Leukemia research : a Forum for Studies on Leukemia and Normal Hemopoiesis20 citations

   Semantic Scholar

   Save

3. Mega Fistulae! A case series

   Ali I. Gardezi, Mustafa Mawih, E. Alrawi, M. S. Karim +2 more

   2020Journal of Vascular Access6 citations

   Semantic Scholar

   Save

4. Azacitidine for Treatment of Therapy Related Myelodysplastic Syndrome

   R. Komrokji, N. Al Ali, E. Alrawi, E. Padron +4 more

   20114 citations

   Semantic Scholar

   Save

5. High Peripheral Blood Stem Cell (PBSC) CD34+ Cell Dose Increases the Risk of Chronic Gvhd after Human Leukocyte Antigen (HLA) Matched Sibling Transplantation

   E. Alrawi, E. Warlick, Q. Cao, M. Arora +6 more

   20162 citations Open access

   Semantic Scholar

   Save

6. 276 Outcome of azacitidine treatment of patients with therapy related myelodysplastic syndrome

   R. Komrokji, E. Alrawi, N. Al Ali, J. Perkins +5 more

   20111 citations

   Semantic Scholar

   Save

7. Umbilical Cord Blood Transplantation and Delay Engraftment Are Associated with Increased Risks of Diffuse Alveolar Hemorrhage

   E. Alrawi, F. Keklik, Q. Cao, N. Bejanyan +6 more

   20160 citations

   Semantic Scholar

   Save